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Abstract The Na+ and K+ dependence of the frontocortical
Na,K-ATPase in Alzheimer’s disease (AD) was compared with
that in human control (Co) and rat AD model. In AD, the
relationship between the Na/K ratio and the Na,K-ATPase ac-
tivity showed noticeable left-shift with three-fold increase in the
enzyme a⁄nity for Na+ (K0:5 = 10 and 30 mM in AD and Co,
respectively). The Na+ dependence of the enzyme in AD showed
two di¡erent Hill coe⁄cients (nH), 1.1 and 0.3, whereas the Co
value of nH was higher (1.4). The rat AD model generated by
ibotenic acid revealed a Na+ dependence similar to AD. The K+
dependence of the Na,K-ATPase showed no signi¢cant di¡er-
ence in AD and Co. Compared with Co, AD produced a shift in
the break of the Na,K-ATPase Arrhenius plot, suggesting re-
markable alterations in the enzyme lipid environment. Our ¢nd-
ings support the hypothesis that dysfunction of the Na,K-ATP-
ase in AD is provoked by altered Na+ dependence of the
enzyme. An impairment of the pump functionality might serve
as an early mechanism of AD that should be interrupted by
selective pharmacological agents.
4 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder,
characterized by a complex of neuronal abnormalities. Prema-
ture loss of neurons in AD has been shown to be associated
with an oxidative stress, impairment of energy metabolism,
membrane dysfunction, disorder of signal transduction, dis-
ruption of ionic homeostasis and with other particular mech-
anisms [1^3]. Previous studies have shown the impairment in
AD brain of the membrane-bound Na,K-ATPase ^ the so-
dium pump mediating the active transmembrane transport
of Naþ and Kþ [4,5]. On the basis of the data obtained in
the human hippocampal synaptosomes and in the cultured rat
hippocampal neurons, it was suggested that the reduction in
the Na,K-ATPase activity is caused by the neurotoxic forms
of amyloid-L peptides (AL) [6]. AL have been shown to induce
membrane lipid peroxidation in the cultured neurons, a pro-
cess which might lead to the impairment of ion-motive ATP-
ases, including Na,K-ATPase [7]. However, a detailed molec-
ular mechanism underlying the dysfunction of Na,K-ATPase
in the brain of AD patients remains unclear. The changes in
the binding of Naþ and Kþ to the Na,K-ATPase followed by
the enzyme downregulation and the elevation of the intracel-
lular ratio of Naþ and Kþ (Nai/Ki) appear to be implicated in
several pathologic conditions, such as hypertension, tumor
genesis, cardiac insu⁄ciency etc. [8]. In this context, it would
be reasonable to suppose that altered binding properties of
Naþ and Kþ to the Na-pump might be related to the genesis
of neuronal dysfunction in AD. To test this, we compared the
speci¢c activity and the Naþ and Kþ dependence of the
Na,K-ATPase in the membranes from AD and age-matched
control frontal cortices, one of the more injured regions in the
AD brain. In parallel, the same parameters were estimated for
the frontocortical Na,K-ATPase from the rat AD model gen-
erated by ibotenic acid. To elucidate whether the alterations in
the regulation of Na,K-ATPase by univalent cations could be
related to the altered protein^lipid interactions of the enzyme,
we determined the temperature (Arrhenius) dependence of
Na,K-ATPase in both, AD and control frontocortical mem-
branes.
2. Materials and methods
2.1. Enzyme preparation and assay
Postmortal tissues from the frontal cortex obtained at autopsy from
six AD patients (age, 85G 4 years) and from six age-matched non-
demented control subjects (age, 78G 6 years) were used in this study.
All AD cases exhibited senile plaques, neuro¢brillary tangles and
other criteria of AD [9], while control brains showed no neuropatho-
logical changes. Immediately after autopsy, the brain tissues were
stored at 375‡C until thawing for isolation of Na,K-ATPase prepa-
rations.
In the parallel experiments, the frontocortical tissue from the rat
AD model was used. The model was generated by bilateral lesion
of the Meynert’s basal magnocellular nuclei in male Wistar rats (240^
260 g) by injecting 0.75 Wl of ibotenic acid (10 Wg/ml) [10]. The rats
were killed by decapitation, the frontocortical areas dissected, and
Na,K-ATPase preparations isolated.
In all cases, the preparations of Na,K-ATPase were isolated accord-
ing to the method described earlier [11]. The tissues were homogenized
at 4‡C in medium containing 0.32 M sucrose, 1 mM EDTA, 0.1%
DOC (deoxycholate) and 37.5 mM imidazole^HCl (pH 7.4 at 8‡C).
The homogenate was centrifuged for 10 min at 10 000Ug and the
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clear supernatant was centrifuged for 30 min at 24 000Ug. The en-
zyme preparation was achieved by resuspension of ¢nal sediment in
the above-described bu¡er (without DOC). The total ATPase activity
was measured by the incubation of the membrane protein (10^20 Wg)
in 375 Wl of medium containing 100 mM NaCl, 20 mM KCl, 4 mM
MgCl2, 4 mM Tris^ATP and 25 mM imidazole^HCl (pH 7.4 at 37‡C).
Variations in incubation conditions are detailed in the appropriate
¢gure legends. The reaction was terminated after 7 min and inorganic
phosphate (Pi) was determined according to [11]. The ouabain-sensi-
tive Na,K-ATPase activity was found as the di¡erence between the
release of Pi from ATP in the absence or presence of 10^100 WM
ouabain in the incubation medium. The protein content in the enzyme
preparation was determined by the method of Lowry et al. [12], using
bovine serum albumin as a standard. Under all experimental condi-
tions, the activity of Na,K-ATPase was linear as a function of incu-
bation time and enzyme amount.
2.2. Other measurements
The relationship between the Naþ/Kþ ratio and the Na,K-ATPase
activity was measured at a constant combined concentration of Naþ
and Kþ (150 mM) in the incubation media. The Hill coe⁄cients (the
degree of cooperativity, nH) and K0:5 (the sodium or potassium con-
centration at which the enzyme reaches half of its maximal activity)
for control and AD Na,K-ATPase were determined by the method
described earlier [13]. The values of nH and K0:5 were calculated from
the Hill plots {log (v/Vmax3v) vs. log [Naþ] or log [Kþ]}, using the
GraphPad Prizm program (version 3.0). The temperature (Arrhenius)
dependence of Na,K-ATPase was studied between 13 and 37‡C and
the data were plotted as log v0 vs. temperature t.
All the experiments were repeated at least three times and means
GS.E.M. were calculated. The unpaired Student t-test was used to
identify signi¢cant di¡erences (P6 0.05) between control and AD
group.
3. Results
Our ¢rst ¢nding was that the speci¢c activity of the Na,K-
ATPase in AD frontal cortex (92G 6 nmol Pi/min/mg protein)
was signi¢cantly (P6 0.05) lower than that in the age-
matched control (151G 30). Similarly, the frontocortical
Na,K-ATPase activity in the ibotenate-generated rat AD
model (690G 10 nmol Pi/min/mg protein) had signi¢cantly de-
creased from the value of the rat control (1160G 110).
Fig. 1 indicates that in the control, the relationship between
the frontocortical Na,K-ATPase activity and the Na/K ratio
in the reaction mixture was signi¢cantly di¡erent from that in
AD. While the control revealed maximal activation of the
enzyme at 130 mM concentration of Naþ (Kþ concentration
20 mM, respectively), in AD, the parameter showed a signi¢-
cant (P6 0.05) left-shift to the Naþ range of 80^100 mM (at
70^50 mM of Kþ). In the control, the half-maximal activation
(K0:5) of the enzyme by Naþ was characterized by a mean
value of 29.5 G 0.9 mM, whereas the same parameter for
AD was 8.7G 0.7 mM. Therefore, a three-fold increase in
the a⁄nity of the enzyme to Naþ was observed in AD com-
pared with the control.
At a ¢xed basic concentration of Kþ (20 mM), the Naþ
dependence of the Na,K-ATPase in AD frontal cortex showed
an interesting di¡erence from that in the control (Fig. 2). In
AD, we could discriminate between two types of cooperative
Naþ e¡ects with the Hill coe⁄cient (nH) values of 1.1
(K0:5 = 4.2 mM) and 0.3 (K0:5 = 0.2 mM), respectively. At the
same time, the control region revealed one linear Hill plot
with nH of 1.4 (K0:5 = 13.3 mM). The Naþ dependence of
the frontocortical Na,K-ATPase in the rat AD model revealed
characteristics quite similar to AD. As shown in Fig. 3, the
bilateral infusion of ibothenic acid induced Naþ e¡ects with
two nH values, whereas in control rats the e¡ect showed one
value of nH. In comparing the Kþ dependence of the Na,K-
ATPase (at 100 mM of Naþ) in AD and human control fron-
Fig. 1. Na/K dependence of the Na,K-ATPase activity in the mem-
branes from Alzheimer’s disease (AD) and control (Co) frontal cor-
tex (% from maximal activity; a typical experiment in duplicate).
Fig. 2. Hill plots for the Naþ dependence of the Na,K-ATPase ac-
tivity in the membranes from AD and Co frontal cortex (a typical
experiment in duplicate). The Hill coe⁄cient (nH) was obtained
from the slope.
Fig. 3. Hill plots for the Naþ dependence of the Na,K-ATPase ac-
tivity in the frontocortical membranes from control (Co) rats and
from rats with ibotenic acid lesion (a typical experiment in dupli-
cate).
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tal cortex, no signi¢cant changes were observed for the values
of nH or K0:5 (Fig. 4). Similarly, the Kþ parameters of the
Na,K-ATPase showed no di¡erence between the ibotenic
acid-injured and the control rat frontal cortex (data not
shown).
In the membranes from the human control frontal cortex,
the Arrhenius plot for the Na,K-ATPase activity revealed a
break at the position of 21.6‡C (Fig. 5). In AD frontal cortex,
the break value increased by 6.4‡C above the control value,
indicating that AD induces phasic transitions in the mem-
brane lipid microenvironment of the Na,K-ATPase.
4. Discussion
The pathogenesis of AD is supposed to involve multiple
factors, including neuronal membrane disorders. The present
study and previous ¢ndings [14] have demonstrated reduced
activity of the membrane-bound Na,K-ATPase (Na-pump) in
the more injured regions of AD brain, suggesting that the
enzyme dysfunction might predispose or accelerate AD pro-
gression. However, the mechanism (probably changes in ion
transport parameters) underlying the dysfunction of Na,K-
ATPase in AD is not clear yet.
Our results showed a signi¢cant left-shift in the Na/K ratio
for the maximum Na-pump stimulation in AD compared with
the control. Such a shift, together with AD-induced increase
in the Naþ a⁄nity, provides evidence for the alteration in the
relative quantity of the Na,K-ATPase conformational forms,
E1Na and E2K, in favor of the E1Na form, in which the
enzyme has been shown to bind preferentially intracellular
sodium [13,15]. The conformational transition of the Na-
pump in AD might be evaluated as an adaptive response to
the reduced Naþ cooperativity, a phenomenon we could real-
ize through the Hill coe⁄cient decrease and Hill plot break
for Naþ in AD. In addition, the expression and association
heterogeneity of K- and L-subunits for the multiple isoforms
of Na,K-ATPase have recently been demonstrated [16]. Since
the prevalent isozyme in the brain, K3L2, has relatively high
a⁄nity for Naþ [16,17] and since the Na,K-ATPase of AD
frontal cortex reveals markedly higher Naþ a⁄nity than the
control, it might be suggested that more injured AD brain
regions are capable of actively expressing the K3L2 and other
Na-a⁄ne isozymes essential for maintaining the regional ionic
homeostasis. It is interesting that cooperativity in Kþ binding
showed no signi¢cant di¡erence in control and AD frontal
cortex. Hence, binding of Kþ to the Na,K-ATPase, mainly
occurring at the enzyme extracellular side [15], seems to be
less susceptible to AD-inducible impairment than binding of
Naþ to the intracellular side. Supporting evidence for our
data has been obtained in the experiments with the rat AD
model. Under the conditions of basal forebrain ibotenic lesion
the rat frontocortical Na-pump showed instability with re-
spect to the Naþ cooperative binding, while the cooperativity
for Kþ was preserved. Taken together, these results coincide
with the previous assumption that certain pathological condi-
tions in the brain, such as tumorigenesis, may interfere with
the Naþ cooperative binding to the Na,K-ATPase and shift
the balance between the conformational forms of the enzyme
[18].
This study revealed a noticeable shift of the break point in
the Na,K-ATPase Arrhenius plot in AD frontal cortex com-
pared with the control, suggesting certain alterations in the
membrane lipid microenvironment (the phase transitions, the
changes of the hydrophobic volume etc.) of the enzyme. Be-
cause the Na,K-ATPase is one of the targets for the neuronal
oxidative stress [19] and because severe oxidative stress is di-
rectly involved in the pathogenesis of AD [20,21], it might be
postulated that the enzyme lipid environment is directly modi-
¢ed by AD-induced high-level lipid peroxidation. Several au-
thors have shown that alterations in the neuronal Na,K-ATP-
ase lipid environment in the pathological and experimental
conditions lead to tighter interaction of the enzyme with the
lipid bilayer [11,16]. This in turn may interfere with protomer-
ic interaction in the oligomeric enzyme protein, resulting in
the decline of its cooperativity for cations, nucleotides and
other regulatory ligands [18,22]. According to our viewpoint,
the altered lipid^protein interactions we were detecting for the
neuronal Na,K-ATPase in AD may underlie the Na-cooper-
ativity failure of the enzyme and its transition to the Na-form.
Impaired Naþ transport by the Na,K-ATPase reportedly
leads to an increase in the intraneuronal sodium and, through
the elevated Na/Ca exchange, in the calcium [23]. In turn,
abnormalities in the calcium dynamics are known to contrib-
ute to neuronal apoptosis and degeneration [24,25].
In summary, our ¢ndings support the hypothesis that al-
tered binding of Naþ to the Na,K-ATPase is a substantial
Fig. 4. Hill plots for the Kþ dependence of the Na,K-ATPase activ-
ity in the membranes from AD and Co frontal cortex (a typical ex-
periment in duplicate). The Hill coe⁄cient (nH) was obtained from
the slope.
Fig. 5. Temperature (Arrhenius) dependence of the Na,K-ATPase
activity in the membranes from AD and Co frontal cortex (v0 : ve-
locity of the enzyme reaction). Values represent meansGS.E.M.,
n=3 per group.
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mechanism leading to the dysfunction and the activity alter-
ation of the enzyme in AD brain. Due to the signi¢cance of
the Na-pump for the maintenance of the physiological Naþ
and Kþ gradients, an impairment of the pump functionality
may be considered as one of the early events accelerating the
progression of AD, particularly in the more a¡ected brain
regions. The fact that some of the functional alterations in
the Na-pump are reversible [26] reinforces the importance of
developing diagnostic tools for the detection of the Na-pump
kinetic parameters and conformational changes in the early
(subclinical) stages of AD. On the other hand, the design and
use of pharmacological agents that can successfully interrupt
the Na-pump-mediated pathologic events in AD brain should
o¡er a good chance for controlling the progression of the
disease.
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